RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinoma
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 564 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in JCO Precision Oncology (April 2024)
Preprint in bioRxiv (March 2024)